StockData
Alvotech logo

Alvotech (ALVO) stock

ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 3/30
$4.55+0.18 (+4.12%)

Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –

Alvotech operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was $78.21M, up 12.3% from the year before. The highest annual figure on record is $78.21M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.21M+12.3%
FY2024Dec 31, 2024$69.64M–
FY2023Dec 31, 2023-$354.86M–
FY2022Dec 31, 2022-$346.44M–
FY2021Dec 31, 2021-$235.46M–
FY2020Dec 31, 2020-$137.54M–

More Alvotech figures

See a number that looks wrong?